These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22960381)

  • 1. Lysophosphatidic acid: chemical signature of neuropathic pain.
    Ueda H; Matsunaga H; Olaposi OI; Nagai J
    Biochim Biophys Acta; 2013 Jan; 1831(1):61-73. PubMed ID: 22960381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain.
    Velasco M; O'Sullivan C; Sheridan GK
    Neuropharmacology; 2017 Feb; 113(Pt B):608-617. PubMed ID: 27059127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid as the initiator of neuropathic pain.
    Ueda H
    Biol Pharm Bull; 2011; 34(8):1154-8. PubMed ID: 21804198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain.
    Ma L; Uchida H; Nagai J; Inoue M; Aoki J; Ueda H
    J Pharmacol Exp Ther; 2010 May; 333(2):540-6. PubMed ID: 20123931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.
    Ma L; Uchida H; Nagai J; Inoue M; Chun J; Aoki J; Ueda H
    Mol Pain; 2009 Nov; 5():64. PubMed ID: 19912636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic acid and its receptors LPA1 and LPA3 mediate paclitaxel-induced neuropathic pain in mice.
    Uchida H; Nagai J; Ueda H
    Mol Pain; 2014 Nov; 10():71. PubMed ID: 25411045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain.
    Inoue M; Ma L; Aoki J; Chun J; Ueda H
    Mol Pain; 2008 Feb; 4():6. PubMed ID: 18261210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid.
    Inoue M; Xie W; Matsushita Y; Chun J; Aoki J; Ueda H
    Neuroscience; 2008 Mar; 152(2):296-8. PubMed ID: 18280050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of lysophosphatidic acid-induced pain with clinically relevant neuropathic pain drugs.
    Ogawa K; Takasu K; Shinohara S; Yoneda Y; Kato A
    Eur J Pain; 2012 Aug; 16(7):994-1004. PubMed ID: 22337641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPA-mediated demyelination in ex vivo culture of dorsal root.
    Fujita R; Kiguchi N; Ueda H
    Neurochem Int; 2007 Jan; 50(2):351-5. PubMed ID: 17056157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain.
    Lin ME; Rivera RR; Chun J
    J Biol Chem; 2012 May; 287(21):17608-17617. PubMed ID: 22461625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury.
    Santos-Nogueira E; López-Serrano C; Hernández J; Lago N; Astudillo AM; Balsinde J; Estivill-Torrús G; de Fonseca FR; Chun J; López-Vales R
    J Neurosci; 2015 Jul; 35(28):10224-35. PubMed ID: 26180199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the sensory nerve fiber responsible for lysophosphatidic acid-induced allodynia in mice.
    Ohsawa M; Miyabe Y; Katsu H; Yamamoto S; Ono H
    Neuroscience; 2013 Sep; 247():65-74. PubMed ID: 23685168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain.
    Ma L; Nagai J; Ueda H
    J Neurochem; 2010 Nov; 115(3):643-53. PubMed ID: 20722972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model.
    Ma L; Nagai J; Chun J; Ueda H
    Mol Pain; 2013 Jun; 9():29. PubMed ID: 23773289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
    Okudaira S; Yukiura H; Aoki J
    Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role of prostaglandin E2 in neuropathic pain: blockade of microglial migration in the spinal cord.
    Kunori S; Matsumura S; Okuda-Ashitaka E; Katano T; Audoly LP; Urade Y; Ito S
    Glia; 2011 Feb; 59(2):208-18. PubMed ID: 21125641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of BoNT/C3-reversible gene expression induced by lysophosphatidic acid: ephrinB1 gene up-regulation underlying neuropathic hyperalgesia and allodynia.
    Uchida H; Matsumoto M; Ueda H
    Neurochem Int; 2009; 54(3-4):215-21. PubMed ID: 19111589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid and signaling in sensory neurons.
    Oude Elferink RP; Bolier R; Beuers UH
    Biochim Biophys Acta; 2015 Jan; 1851(1):61-5. PubMed ID: 25218302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratrigeminal ganglionic injection of LPA causes neuropathic pain-like behavior and demyelination in rats.
    Ahn DK; Lee SY; Han SR; Ju JS; Yang GY; Lee MK; Youn DH; Bae YC
    Pain; 2009 Nov; 146(1-2):114-20. PubMed ID: 19665300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.